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The following list presents the current evidence 
on back of the eye treatments, as well as 
reviews which are planned or underway. All 
Cochrane reviews and protocols are completed 
using strict methodology and are peer-reviewed 
at both protocol and review stage. They are 
published in The Cochrane Database of 
Systematic Reviews, one of several databases 
in The Cochrane Library.
Published reviews
A published review follows a structured format 
detailing, among other things, methods used, 
inclusion/exclusion criteria, search strategies for 
finding randomised controlled trials, and meta-
analysis (where performed). CEVG-published 
reviews relevant to back of the eye treatments are: 
• Antioxidant vitamin and mineral supplements 
for age-related macular degeneration
• Antioxidant vitamin and mineral supplements for 
preventing age-related macular degeneration
• Ginkgo Biloba extract for age-related macular 
degeneration
• Interventions for acute central retinal artery 
occlusion
• Interventions for asymptomatic retinal breaks 
and lattice degeneration for preventing retinal 
detachment
• Laser photocoagulation for choroidal neovas-
cularisation in pathologic myopia
• Non-steroidal anti-inflammatory agents for 
treating cystoid macular oedema following 
cataract surgery
• Photodynamic therapy for neovascular age-
related macular degeneration 
• Radiotherapy for exudative age-related 
macular degeneration.
Published protocols
A published protocol outlines the background, 
rationale and methods of the review. CEVG-
published protocols relevant to back of the eye 
treatments are: 
• Antiangiogenic therapy with anti-VEGF 
modalities for neovascular age-related 
macular degeneration
• Haemodilution treatment for retinal vein 
occlusion
• Interventions for acute retinal necrosis
• Intravitreal steroids for macular oedema in 
diabetes
• Laser photocoagulation for neovascular age-
related macular degeneration
• Surgical implantation of steroids with antian-
giogenic characteristics for treating exudative 
macular degeneration.
Working titles
A working title is a protocol in progress prior to 
being submitted for publication. Working titles 
dealing with back of the eye treatments 
currently registered with CEVG are: 
• Acupuncture for age-related macular degen-
eration
• Blood pressure control for the management 
of diabetic retinopathy
• Calcium dobesilate for diabetic retinopathy
• Carbonic anhydrase inhibitors for cystoid 
macular oedema
• Chinese herbal treatment for diabetic retinopathy
• Fish oils and vitamin A for hereditary retinal 
disease
• Intravitreal steroid for retinal vein occlusion
• Laser photocoagulation for retinal vein occlusion
• Laser treatment for diabetic retinopathy
• Laser treatment of drusen in age-related 
macular degeneration
• Pars plana vitrectomy for diabetic macular 
oedema
• Pharmacotherapy for preventing proliferative 
vitreoretinopathy in retinal detachment surgery
• Statins for age-related macular degeneration
• Sub-threshold laser treatment for diabetic 
maculopathy
• Surgical interventions for repairing simple 
rhegmatogenous retinal detachments
• Tamponade in surgery for retinal detachment 
associated with proliferative vitreoretinopathy
• Traditional Chinese medicine for retinitis 
pigmentosa.
Available titles
CEVG invites people from around the world 
interested in preparing a review on the following 
titles that do not have authors. Available titles 
for CEVG reviews in the area of back of the eye 
treatments are: 
• Interventions for cytomegalovirus retinitis
• Sub-macular surgery for age-related macular 
degeneration.
Access to Cochrane 
systematic reviews
The Cochrane Library is available by 
subscription, either on CD-ROM or via the 
internet. Residents in a number of countries, 
including Australia, New Zealand and South 
Africa, can access the Library free of charge 
through a ‘national provision’. Higher Education 
and Further Education residents can access the 
Library using an Athens password. 
Further information
You can either visit the CEVG website at 
www.cochraneeyes.org or email Anupa Shah, 
Review Group Co-ordinator at cevg@lshtm.ac.uk
blasts within the developing 
retina. It is the most common 
primary intraocular malignancy 
of childhood. Most cases 
occur in children younger 
than six years of age.
The most common 
presenting symptoms of 
retinoblastoma are leukocoria 
(a white pupil), in the tumour-
containing eye or eyes, 
strabismus or symptomatic 
or asymptomatic visual loss. 
Retinoblastoma can be 
hereditary.
Retinal dystrophies – 
Retinitis pigmentosa 
(RP)
A group of hereditary retinal 
conditions that cause 
degeneration of the retina. 
Retinal cells are among 
the most specialised cells 
in the human body and 
depend on a number of 
unique genes to create 
vision. A disease-causing 
mutation in any one of 
these genes can lead to 
vision loss. RP results from 
a large and as yet unknown 
number of gene defects, 
of which around a hundred 
have been found so far. 
RP can be passed to 
succeeding generations by 
one of three genetic 
inheritance patterns: 
autosomal dominant, 
autosomal recessive, or 
X-linked inheritance. RP 
causes the degeneration of 
photoreceptor cells from the 
outer edges of the retina, 
causing a progressive loss of 
peripheral vision, night 
blindness and reduced or 
absent electroretinogram 
(ERG) recordings.
Cochrane eyes and Vision Group
International Centre for Eye Health, London 
School of Hygiene & Tropical Medicine, 
Keppel Street, London, WC1E 7HT, UK.
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